Polyol pathway inhibition by epalrestat attenuates pathological bone loss through redox homeostasis and sorbitol-linked calcium signaling.
- DOI
- 10.1016/j.phrs.2026.109698
- Published
- 2026 Oct 24
- Container
- Pharmacological research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.phrs.2026.109698,
title = {Polyol pathway inhibition by epalrestat attenuates pathological bone loss through redox homeostasis and sorbitol-linked calcium signaling.},
author = {Yao C and Cai Z and Song H and Xue Q and Cai B and He W and Kong X and Yang T and Jin J and Li J and Chen B and Zhao F and Chen J and Chen J and Liu J},
year = {2026},
journal = {Pharmacological research},
doi = {10.1016/j.phrs.2026.109698},
url = {https://doi.org/10.1016/j.phrs.2026.109698}
}RIS
TY - JOUR TI - Polyol pathway inhibition by epalrestat attenuates pathological bone loss through redox homeostasis and sorbitol-linked calcium signaling. AU - Yao C AU - Cai Z AU - Song H AU - Xue Q AU - Cai B AU - He W AU - Kong X AU - Yang T AU - Jin J AU - Li J AU - Chen B AU - Zhao F AU - Chen J AU - Chen J AU - Liu J PY - 2026 JO - Pharmacological research DO - 10.1016/j.phrs.2026.109698 UR - https://doi.org/10.1016/j.phrs.2026.109698 ER -
APA
C, Y., Z, C., H, S., Q, X., B, C., W, H., X, K., T, Y., J, J., J, L., B, C., F, Z., J, C., J, C., & J, L. (2026). Polyol pathway inhibition by epalrestat attenuates pathological bone loss through redox homeostasis and sorbitol-linked calcium signaling.. Pharmacological research. https://doi.org/10.1016/j.phrs.2026.109698
Source records
- pubmed · retrieved 2026-11-10T10:28:20.737Z